Biocare Corporation

BioCare was established at the beginning of 1997 with a start-up capital of U. S. $7.4M. It is a subsidiary of Koo's Group, one of Taiwan's most influential enterprises. Its parent corporation, Grand Pacific Venture Capital Corporation of Koo's Group, owns 50% of its shares.

With strong governmental support, the health care and biotechnology industry in Taiwan is expected to be the emphasis of 21st Century. With growing work force, BioCare dedicates its professionals to develop the best products and services worldwide. Our R&D and quality system have been certified by German VDE for ISO9001 and EN46001.

Being a frontier in the health care industry, BioCare's core competence technology, the BIOSENSOR, has won many awards and supports from the government. With this technology, BioCare was able to develop an on-line hemodialysis bedside bioanalyzer -Biotrack TM. This on-line urea monitor can detect the quality of the hemodialysis treatment. Through calculated indexes, such as Kt/V, nPCR, SRI, patients and doctors can easily and conveniently learn about the adequacy of the hemodialysis treatment.

Other than hemodialysis products, BioCare is currently developing and evaluating other products in the pharmaceutical and therapeutic fields. Our mission is to become the leading medical diagnostic instrumentation manufacturer and at the same time, the leading Asian Pacific Marketing Center for medical diagnostic and therapeutic instrumentation. In addition, BioCare has dedicated its strong engineering team for the OEM of leading medical manufacturers. New products that were recently developed are Biolyte(electrolyteanalyzer), and Stripmax(Urinestrip analyzer).